December 2020 FDA Recall Sodium Chloride by Hikma Pharmaceuticals Usa Inc.
D-0169-2021 - Failed pH Specifications
This Class II drug recall was voluntarily initiated by Hikma Pharmaceuticals Usa Inc. on December 7, 2020 for the product Sodium Chloride. The FDA reported the reason for recall as failed ph specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0169-2021
Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2ml vial.
12-07-2020
12-23-2020
1,324,072 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Hikma Pharmaceuticals USA Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Distributed Nationwide in the USA
07-18-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/ml, 2mL Single Dose Vial, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, Vial NDC 0641-0497-17
Batch or Lot Expiration Information
Lot# : 048315 EXP 4/2021; 068320 EXP 6/2021; 128302 EXP 12/2021; 099349 EXP 9/2022.